Inhibikase Therapeutics Inc. Gains 37.67%

Wed, Jan 24, 2024 at 07:25 PM
Inhibikase Therapeutics Inc. Gains 37.67%

Inhibikase Therapeutics Inc. (IKT:NASDAQ) rocketted at $2.96, representing a gain of 37.7%. On Wed, Jan 24, 2024, IKT:NASDAQ hit a New 2-Week High of $2.96. From Wed, Jan 10, 2024, the stock recorded 66.67% Up Days and 70.00% Green Days

About Inhibikase Therapeutics Inc. (IKT:NASDAQ)

Inhibikase Therapeutics Inc is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.